ChemicalBook >> CAS DataBase List >>Indacaterol

Indacaterol

CAS No.
312753-06-3
Chemical Name:
Indacaterol
Synonyms
CS-272;Arcapta;Indaterol;Indacaterol;Indacaterol-d3;Indacaterol (Onbrez;Indacaterol USP/EP/BP;Indacaterol acetate salt;Indacaterol and its intermediates;Procaterol Impurity 17 ammonium salt
CBNumber:
CB82512068
Molecular Formula:
C24H28N2O3
Molecular Weight:
392.49
MDL Number:
MFCD18782702
MOL File:
312753-06-3.mol
MSDS File:
SDS
Last updated:2023-11-07 17:33:14

Indacaterol Properties

Melting point >165°C (dec.)
Boiling point 660.3±55.0 °C(Predicted)
Density 1.27
storage temp. -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
pka 8.68±0.20(Predicted)
form Solid
color Off-White to Light Yellow
InChIKey QZZUEBNBZAPZLX-QFIPXVFZSA-N
SMILES N1C2=C(C([C@@H](O)CNC3CC4=C(C3)C=C(CC)C(CC)=C4)=CC=C2O)C=CC1=O
FDA UNII 8OR09251MQ
ATC code R03AC18

Indacaterol price More Price(29)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 20070 Indacaterol ≥98% 312753-06-3 50mg $49 2024-03-01 Buy
Cayman Chemical 20070 Indacaterol ≥98% 312753-06-3 100mg $92 2024-03-01 Buy
Cayman Chemical 20070 Indacaterol ≥98% 312753-06-3 250mg $216 2024-03-01 Buy
Cayman Chemical 20070 Indacaterol ≥98% 312753-06-3 500mg $380 2024-03-01 Buy
Cayman Chemical 28886 Indacaterol-d3 312753-06-3 1mg $375 2021-12-16 Buy
Product number Packaging Price Buy
20070 50mg $49 Buy
20070 100mg $92 Buy
20070 250mg $216 Buy
20070 500mg $380 Buy
28886 1mg $375 Buy

Indacaterol Chemical Properties,Uses,Production

Description

Indacaterol is a new, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist that was developed by Novartis. The drug is used in managing and controlling chronic obstructive pulmonary disease (COPD) and asthma. The European Medicines Agency (EMA) approved indacaterol as a drug in 2009 under the Onbrez trade name while in the United States the Food and Drug Administration approved it under the trade name Arcapta in 2011. The drug is manufactured as its maleate salt form. Also, indacaterol is a chiral molecule; however, only the pure R-enantiomer is distributed.

Indication

Indacaterol is used in the maintenance of airflow obstruction in individuals with COPD for the long term, including emphysema and chronic bronchitis.

Mechanism of Action

By stimulating the adrenergic beta-2-receptors in the airways’ smooth muscles, indacaterol is able to cause relaxation, thus augmenting the diameter of the airways that are normally constricted in COPD and asthma. Because of its high affinity to the lipid draft domains in the membrane of the airways, it is long acting, therefore it slowly detaches from the receptors. It is rapid acting due to its high intrinsic characteristic.

Toxicity

In case of an overdose of indacaterol, the expected signs and symptoms include excessive beta-adrenergic stimulation, hypotension, hypertension, nervousness, fatigue, hyperglycaemia, insomnia, and metabolic acidosis.

Description

Inhaled β2 adrenoceptor agonists are effective in the management of asthma and COPD, primarily through their bronchodilating properties. These drugs induce bronchodilation by causing direct relaxation of airway smooth muscle through activation of adenylate cyclase, which in turn increases intracellular cAMP levels. Indacaterol is the newest β2 agonist to reach the market. It is an ultra-long-acting agent with a duration of action suitable for once-a-day dosing. Indacaterol is supplied as an aerosol formulation of its maleate salt and is administered via a dry powder inhaler device. It is specifically approved for once-daily maintenance treatment of airflow obstruction in adult patients with COPD. In preclinical models, indacaterol is close to a full agonist at the human b2 adrenoceptor (Emax = 73 ± 1% of isoprenaline′s maximal effect, pEC50 = 8.06 ±0.02) while salmeterol displays only partial efficacy (38 ±1%). The functional selectivity profile of indacaterol over β1 human adrenoceptors is similar to that of formoterol, whereas its β3 adrenoceptor selectivity profile is similar to that of formoterol and salbutamol.

Originator

Novartis (United Kingdom)

Uses

Indacaterol is a β-adrenoreceptor agonists for treatment of asthma and bronchodilator treatment for patients with chronic obstructive pulmonary diseases.

Definition

ChEBI: A monohydroxyquinoline that consists of 5-[(1R)-2-amino-1-hydroxyethyl]-8-hydroxyquinolin-2-one having a 5,6-diethylindan-2-yl group attached to the amino function. Used as the maleate salt for treatment of chronic obstructive pulmonary di ease.

brand name

Onbrez Breezhaler

Side effects

The most commonly reported adverse events associated with indacaterol treatment were nasopharyngitis, upper respiratory tract infection, and headache and cough following inhalation. Adverse events were mild or moderate in most cases, and became less frequent with continued treatment.

Synthesis

The chemical synthesis of indacaterol begins with a-chlorination of 5-acetyl-8-benzyloxy-2-quinolone with benzyltrimethylammonium dichloro-iodate. The resultant chloroketone is reduced with borane in tetrahydrofuran in the presence of the chiral boron catalyst R-tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo[1,2c][ 1,3,2]oxazaborole to produce the corresponding chlorohydrin intermediate in high enantiomeric excess. The chlorohydrin intermediate is cyclized to the corresponding epoxide by treatment with potassium carbonate, the epoxide is condensed with 5,6-diethylindan-2-amine, and the benzyl protecting group is removed by hydrogenolysis to produce indacaterol. The 5,6-diethylindan-2-amine intermediate is derived from 1,2-diethylbenzene via Friedel-Crafts acylation with 3-chloropropionyl chloride, cyclization of the resultant 3-chloro- 1-(3,4-diethylphenyl)-1-propanone by means of concentrated sulfuric acid to 5,6-diethylindan-1-one, oximation with butyl nitrite, and reduction of the oxime to an amine via treatment with hydrogen over palladium- carbon.

435273-75-9
312753-06-3
Synthesis of Indacaterol from Indacaterol interMediate
Global( 168)Suppliers
Supplier Tel Email Country ProdList Advantage
AFINE CHEMICALS LIMITED
0571-85134551 info@afinechem.com CHINA 15377 58
Jinan Million Pharmaceutical Co., Ltd
+86-531-68659554 +8613031714605 info@millionpharm.com China 153 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152 Mandy@hangyubiotech.com China 11013 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21695 55
Nanjing Finetech Chemical Co., Ltd.
025-85710122 17714198479 sales@fine-chemtech.com CHINA 885 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58

View Lastest Price from Indacaterol manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Indacaterol pictures 2024-04-19 Indacaterol
312753-06-3
US $2.00 / kg 1kg 99% 80KG/M Jinan Million Pharmaceutical Co., Ltd
Indacaterol pictures 2024-01-02 Indacaterol
312753-06-3
US $70.00-700.00 / kg 10kg 0.99 20tons Zibo Hangyu Biotechnology Development Co., Ltd
Indacaterol pictures 2021-07-13 Indacaterol
312753-06-3
US $15.00-10.00 / KG 1KG 99%+ HPLC Monthly supply of 1 ton Zhuozhou Wenxi import and Export Co., Ltd
  • Indacaterol pictures
  • Indacaterol
    312753-06-3
  • US $2.00 / kg
  • 99%
  • Jinan Million Pharmaceutical Co., Ltd
  • Indacaterol pictures
  • Indacaterol
    312753-06-3
  • US $70.00-700.00 / kg
  • 0.99
  • Zibo Hangyu Biotechnology Development Co., Ltd
  • Indacaterol pictures
  • Indacaterol
    312753-06-3
  • US $15.00-10.00 / KG
  • 99%+ HPLC
  • Zhuozhou Wenxi import and Export Co., Ltd

Indacaterol Spectrum

Indacaterol 5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one (R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylaMino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, Maleate salt Arcapta 5-[2-(5,6-Diethyl-2,3-dihydro-1H-inden-2-ylaMino)-(1R)-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one (R)-5-(2-(5,6-Diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)- 2(1H)-Quinolinone,5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy- Indacaterol-d3 CS-272 Indacaterol and its intermediates Indacaterol USP/EP/BP Indacaterol acetate salt 5-[2-(5,6-Diethyl-2,3-dihydro-1H-inden-2-ylamino)-(1R)-hydro... IndacaterolQ: What is Indacaterol Q: What is the CAS Number of Indacaterol Q: What is the storage condition of Indacaterol Q: What are the applications of Indacaterol asthma,Beta Receptor,HT1080 cells,myocardial infarction,Adrenergic Receptor,NF-κB,β-arrestin2,Indacaterol,Inhibitor,COPD,inhibit,heart failure Indacaterol /5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one Procaterol Impurity 17 ammonium salt Indaterol Indacaterol (Onbrez (R) -5-[2- (5, 6-diethyldihydroindene-2-amino) -1-hydroxyethyl] -8-hydroxy-1H-quinolin-2-one 312753-06-3 Intermediates & Fine Chemicals Pharmaceuticals Inhibitors Agonist Amines Aromatics Heterocycles